R. Weil, D. Palmieri, J. Bronder, A. Stark, and P. Steeg, Breast Cancer Metastasis to the Central Nervous System, The American Journal of Pathology, vol.167, issue.4, pp.913-933, 2005.
DOI : 10.1016/S0002-9440(10)61180-7

M. Mehta and D. Khuntia, Current Strategies in Whole-brain Radiation Therapy for Brain Metastases, Neurosurgery, vol.57, issue.Supplement, pp.33-44, 2005.
DOI : 10.1227/01.NEU.0000182742.40978.E7

M. Mehta, M. Tsao, T. Whelan, D. Morris, J. Hayman et al., The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.1, pp.37-46, 2005.
DOI : 10.1016/j.ijrobp.2005.05.023

L. Schouten, J. Rutten, H. Huveneers, and A. Twijnstra, Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma, Cancer, vol.144, issue.10, pp.2698-705, 2002.
DOI : 10.1002/cncr.10541

J. Barnholtz-sloan, A. Sloan, F. Davis, F. Vigneau, P. Lai et al., Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System, Journal of Clinical Oncology, vol.22, issue.14, pp.2865-72, 2004.
DOI : 10.1200/JCO.2004.12.149

M. Lorger and B. Felding-habermann, Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis, The American Journal of Pathology, vol.176, issue.6, pp.2958-71, 2010.
DOI : 10.2353/ajpath.2010.090838

K. Yonemori, K. Tsuta, M. Ono, C. Shimizu, A. Hirakawa et al., -positive breast cancer, Cancer, vol.13, issue.2, pp.302-310, 2010.
DOI : 10.1002/cncr.24735

B. Gril, D. Palmieri, Y. Qian, D. Smart, L. Ileva et al., Pazopanib Reveals a Role for Tumor Cell B-Raf in the Prevention of HER2+ Breast Cancer Brain Metastasis, Clinical Cancer Research, vol.17, issue.1, pp.142-53, 2011.
DOI : 10.1158/1078-0432.CCR-10-1603

G. Chen and M. Davies, Emerging insights into the molecular biology of brain metastases, Biochemical Pharmacology, vol.83, issue.3, pp.305-319, 2012.
DOI : 10.1016/j.bcp.2011.09.012

A. Britschgi, T. Radimerski, and M. Bentires-alj, Targeting PI3K, HER2 and the IL-8/JAK2 axis in metastatic breast cancer: Which combination makes the whole greater than the sum of its parts?, Drug Resistance Updates, vol.16, issue.3-5, pp.3-568, 2013.
DOI : 10.1016/j.drup.2013.10.001

A. Mehta and D. Tripathy, Co-targeting estrogen receptor and HER2 pathways in breast cancer, The Breast, vol.23, issue.1, pp.2-9, 2014.
DOI : 10.1016/j.breast.2013.09.006

R. Patel and M. Mehta, Targeted Therapy for Brain Metastases: Improving the Therapeutic Ratio, Clinical Cancer Research, vol.13, issue.6, pp.1675-83, 2007.
DOI : 10.1158/1078-0432.CCR-06-2489

G. Robinet, P. Thomas, J. Breton, H. Lena, S. Gouva et al., Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: groupe francais de pneumo-cancerologie (GFPC) protocol 95-1, Annals of Oncology, vol.12, issue.1, pp.59-67, 2001.
DOI : 10.1023/A:1008338312647

P. Metellus, T. Faillot, J. Guyotat, W. Farah, L. Bauchet et al., Place of surgery in brain metastases], Bull Cancer, vol.100, issue.1, pp.51-57, 2013.

W. Boogerd, F. Groenveld, S. Linn, J. Baars, D. Brandsma et al., Chemotherapy as primary treatment for brain metastases from breast cancer: analysis of 115 one-year survivors, Journal of Cancer Research and Clinical Oncology, vol.52, issue.8, pp.1395-403, 2012.
DOI : 10.1007/s00432-012-1218-y

P. Bos, X. Zhang, C. Nadal, W. Shu, R. Gomis et al., Genes that mediate breast cancer metastasis to the brain, Nature, vol.6, issue.7249, pp.1005-1014, 2009.
DOI : 10.1038/nature08021

B. Gril, L. Evans, D. Palmieri, and P. Steeg, Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies, European Journal of Cancer, vol.46, issue.7, pp.1204-1214, 2010.
DOI : 10.1016/j.ejca.2010.02.033

L. Zhang, P. Sullivan, J. Goodman, P. Gunaratne, and D. Marchetti, MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase, Cancer Research, vol.71, issue.3, pp.645-54, 2011.
DOI : 10.1158/0008-5472.CAN-10-1910

D. White and W. Muller, Multifaceted Roles of Integrins in Breast Cancer Metastasis, Journal of Mammary Gland Biology and Neoplasia, vol.2, issue.3, pp.2-3135, 2007.
DOI : 10.1007/s10911-007-9045-5

V. Dieras and J. Pierga, [Brain metastasis of breast tumors and blood brain barrier], Bull Cancer, vol.98, issue.4, pp.385-394, 2011.

N. Houssami, P. Macaskill, R. Balleine, M. Bilous, and M. Pegram, HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis, Breast Cancer Research and Treatment, vol.19, issue.3, pp.659-74, 2011.
DOI : 10.1007/s10549-011-1632-x

R. Duchnowska, R. Dziadziuszko, T. Trojanowski, T. Mandat, W. Och et al., Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain, Breast Cancer Research, vol.29, issue.suppl, p.119, 2012.
DOI : 10.1038/labinvest.3700543

I. Fuchs, M. Loebbecke, H. Buhler, G. Stoltenburg-didinger, B. Heine et al., in Brain Metastases: Issues of Concordance, Survival, and Treatment, Journal of Clinical Oncology, vol.20, issue.19, pp.4130-4133, 2002.
DOI : 10.1200/JCO.2002.04.016

K. Lear-kaul, H. Yoon, B. Kleinschmidt-demasters, L. Mcgavran, and M. Singh, Her- 2/neu status in breast cancer metastases to the central nervous system, Arch Pathol Lab Med, vol.127, issue.11, pp.1451-1458, 2003.

S. Edgerton, D. Moore, D. Merkel, and A. Thor, erbB-2 (HER-2) and Breast Cancer Progression, Applied Immunohistochemistry & Molecular Morphology, vol.11, issue.3, pp.214-235, 2003.
DOI : 10.1097/00129039-200309000-00003

L. Hoefnagel, M. Van-de-vijver, H. Van-slooten, P. Wesseling, J. Wesseling et al., Receptor conversion in distant breast cancer metastases, Breast Cancer Research, vol.14, issue.5, p.75, 2010.
DOI : 10.1158/1078-0432.CCR-07-4082

H. Kim, X. Xu, S. Yoo, P. Sun, Y. Jin et al., Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases, Histopathology, vol.51, issue.2, pp.305-319, 2013.
DOI : 10.1111/j.1365-2559.2012.04356.x

B. Dai, X. Cai, Y. Kong, F. Yang, X. Shen et al., Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences, Human Pathology, vol.44, issue.8, pp.1472-1480, 2013.
DOI : 10.1016/j.humpath.2013.01.007

M. Santoni, D. Santini, F. Massari, A. Conti, R. Iacovelli et al., Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside, Cancer and Metastasis Reviews, vol.30, issue.6, pp.321-352, 2014.
DOI : 10.1007/s10555-013-9453-5

K. Johung, X. Yao, F. Li, J. Yu, S. Gettinger et al., A Clinical Model for Identifying Radiosensitive Tumor Genotypes in Non-Small Cell Lung Cancer, Clinical Cancer Research, vol.19, issue.19, pp.5523-5555, 2013.
DOI : 10.1158/1078-0432.CCR-13-0836

A. Chien and H. Rugo, Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer, Breast Cancer Research and Treatment, vol.73, issue.1, pp.1-12, 2013.
DOI : 10.1007/s10549-012-2328-6

P. Larsen, I. Kümler, and D. Nielsen, A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer, Cancer Treatment Reviews, vol.39, issue.7, pp.720-727, 2013.
DOI : 10.1016/j.ctrv.2013.01.006

R. Broom, P. Tang, C. Simmons, L. Bordeleau, A. Mulligan et al., Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer, Anticancer Res, vol.29, issue.5, pp.1557-62, 2009.